DE60107284D1 - Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern - Google Patents

Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern

Info

Publication number
DE60107284D1
DE60107284D1 DE60107284T DE60107284T DE60107284D1 DE 60107284 D1 DE60107284 D1 DE 60107284D1 DE 60107284 T DE60107284 T DE 60107284T DE 60107284 T DE60107284 T DE 60107284T DE 60107284 D1 DE60107284 D1 DE 60107284D1
Authority
DE
Germany
Prior art keywords
determination
vaginalis
gvh
gardnerella
iga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60107284T
Other languages
English (en)
Other versions
DE60107284T2 (de
Inventor
Sabina Cauci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIBIO Srl
Original Assignee
UNIBIO Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIBIO Srl filed Critical UNIBIO Srl
Application granted granted Critical
Publication of DE60107284D1 publication Critical patent/DE60107284D1/de
Publication of DE60107284T2 publication Critical patent/DE60107284T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60107284T 2001-02-15 2001-02-15 Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern Expired - Fee Related DE60107284T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2001/000068 WO2002065130A1 (en) 2001-02-15 2001-02-15 Diagnostic method for bacterial vaginosis based on detecting antibodies against gvh toxin of gardnerella vaginalis

Publications (2)

Publication Number Publication Date
DE60107284D1 true DE60107284D1 (de) 2004-12-23
DE60107284T2 DE60107284T2 (de) 2005-12-29

Family

ID=11133621

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60107284T Expired - Fee Related DE60107284T2 (de) 2001-02-15 2001-02-15 Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern

Country Status (5)

Country Link
US (1) US20040101918A1 (de)
EP (1) EP1336106B1 (de)
AT (1) ATE282829T1 (de)
DE (1) DE60107284T2 (de)
WO (1) WO2002065130A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095660A1 (en) * 2003-10-31 2005-05-05 Unibio, S.R.I. Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women
US8492098B2 (en) * 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
ES2556627T3 (es) 2007-08-30 2016-01-19 Trustees Of Tufts College Métodos para determinar la concentración de un analito en solución
US8222047B2 (en) * 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
US20100075862A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
US8415171B2 (en) 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
WO2011109379A1 (en) 2010-03-01 2011-09-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
GB201812331D0 (en) * 2018-07-27 2018-09-12 Mologic Ltd Bacterial vaginosis diagnostic
CN112114151B (zh) * 2020-08-20 2022-03-01 深圳爱信生物技术有限公司 一种2019-nCoV的IgG、IgM和IgA抗体联合检测试剂盒及其检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700636A (en) * 1990-10-19 1997-12-23 Becton Dickinson And Company Methods for selectively detecting microorganisms associated with vaginal infections in complex biological samples
US5571684A (en) * 1994-11-07 1996-11-05 Litmus Concepts, Inc. Assay for proline iminopeptidase and other hydrolytic activities
CN1503908A (zh) * 2001-02-15 2004-06-09 妇女体液样品中涉及存在唾液酸酶或氨酰基脯氨酸二酞酶活性的病理风险确定的酶检验方法
US20050095660A1 (en) * 2003-10-31 2005-05-05 Unibio, S.R.I. Enzyme activities and pH tests for the determination of the risk of obstetric and gynecologic complications in samples of body fluids of women

Also Published As

Publication number Publication date
DE60107284T2 (de) 2005-12-29
EP1336106B1 (de) 2004-11-17
ATE282829T1 (de) 2004-12-15
WO2002065130A1 (en) 2002-08-22
EP1336106A1 (de) 2003-08-20
US20040101918A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
DE60107284D1 (de) Diagnostisches verfahren zur erkennung von bakterieller vaginose auf basis der bestimmung von anti-gardnerella-vaginalis-gvh-toxin antikörpern
BR9507594B1 (pt) anticorpo monoclonal com scfv humanizado, molécula de ácido nucleico recombinante e proteìna recombinante.
Kirkeby et al. Immunoglobulins in nasal secretions of healthy humans: structural integrity of secretory immunoglobulin A1 (IgA1) and occurrence of neutralizing antibodies to IgA1 proteases of nasal bacteria
EP1231268A3 (de) Bibliotheken aus Polyklonalen Antikörpern
ATE290375T1 (de) Verwendung eines mittels zur verminderung des risikos kardiovaskulärer erkrankungen
US8124107B2 (en) Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
Claßen et al. TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP‐1, and downstream gene transcription
CY1107901T1 (el) Μεθοδος προσδιορισμου για ασθενεια alzheimer
Moss et al. Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus
DE60045931D1 (de) Menschliches Rezeptor für Zytokine
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
ES2109242T3 (es) Anticuerpos monoclonales contra inmunoglobulina e humana.
DK1353688T3 (da) Fremgangsmåde og sammensætninger til immunisering med Psedomonas V-antigenet
ATE415629T1 (de) In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion
Schneiderman et al. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
Palm et al. Secretory immunoglobulin A and immunoglobulin G in horse saliva
EP3002292A1 (de) Verfahren zur diagnose von bakterieninfektionen mit dem propionibakterium
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
WO2003013594A3 (en) Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation
BRPI0418126A (pt) método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles
DE60007195D1 (de) Antikörper und Diagnostizierverfahren zur Pestivirusdiagnose
PT783520E (pt) Anticorpos opsonicos amplamente reactivos que reagem com antigenios de estafilococos comuns
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
ATE360212T1 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee